Antonio Oliver

24.4k total citations · 4 hit papers
309 papers, 13.8k citations indexed

About

Antonio Oliver is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Antonio Oliver has authored 309 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Molecular Medicine, 122 papers in Molecular Biology and 98 papers in Pharmacology. Recurrent topics in Antonio Oliver's work include Antibiotic Resistance in Bacteria (231 papers), Bacterial biofilms and quorum sensing (106 papers) and Antibiotics Pharmacokinetics and Efficacy (98 papers). Antonio Oliver is often cited by papers focused on Antibiotic Resistance in Bacteria (231 papers), Bacterial biofilms and quorum sensing (106 papers) and Antibiotics Pharmacokinetics and Efficacy (98 papers). Antonio Oliver collaborates with scholars based in Spain, United States and Australia. Antonio Oliver's co-authors include María D. Macià, Carlos Juan, Carla López-Causapé, Rafael Cantón, Estrella Rojo‐Molinero, Fernando Baquero, Gabriel Cabot, Xavier Mulet, Bartolomé Moyá and Jesús Blázquez and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Antonio Oliver

301 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

2019 625 citations Antonio Oliver, Natividad Benito et al. profile →
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

2015 580 citations Antonio Oliver et al. profile →
The increasing threat of Pseudomonas aeruginosa high-risk clones

2015 478 citations Antonio Oliver, Carla López-Causapé et al. profile →
Antimicrobial susceptibility testing in biofilm-growing bacteria

2014 402 citations María D. Macià, Estrella Rojo‐Molinero et al. profile →

Peers

Countries citing papers authored by Antonio Oliver

Since Specialization

Citations

This map shows the geographic impact of Antonio Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Oliver more than expected).

Fields of papers citing papers by Antonio Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Oliver. The network helps show where Antonio Oliver may publish in the future.

Co-authorship network of co-authors of Antonio Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Oliver. A scholar is included among the top collaborators of Antonio Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Oliver. Antonio Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MGE- Acr Clusters in Pseudomonas aeruginosa Clinical Isolates 2025 ·(unknown), Laura Fernández-García, Carla López-Causapé, Lucía Blasco, Inés Bleriot, (unknown), (unknown), (unknown), Rafael Cantón, Antonio Oliver, María Tomás	0
2	Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions 2024 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), (unknown), (unknown), (unknown), Inmaculada López-Hernández, Marı́a Pérez-Vázquez, Belén Aracil, Lorena López‐Cerero, Pablo A. Fraile-Ribot, Antonio Oliver, Juan Carlos Vázquez-Ucha, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez	17
3	Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential 2023 ·FEMS Microbiology Reviews ·(unknown), Isabel M. Barceló, Elena Jordana‐Lluch, Gabriel Torrens, Antonio Oliver, Carlos Juan	9
4	Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity 2023 ·International Journal of Antimicrobial Agents ·Akosua Adom Agyeman, Carla López-Causapé, Kate E. Rogers, Deanna Deveson Lucas, Sara Cortés-Lara, María A. Gomis-Font, Pablo A. Fraile-Ribot, Joan Figuerola, Yinzhi Lang, (unknown), Wee Leng Lee, Jieqiang Zhou, Yong‐Zhen Zhang, Jürgen B. Bulitta, John D. Boyce, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer	10
5	Visible‐Light‐Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload 2023 ·Advanced Science ·Ana L. Santos, Jacob L. Beckham, Dongdong Liu, Gang Li, (unknown), Antonio Oliver, George P. Tegos, James M. Tour	13
6	Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital 2023 ·Infection Control and Hospital Epidemiology ·Ana Gual-de-Torrella, Carla López-Causapé, Izaskun Alejo-Cancho, Estrella Rojo‐Molinero, (unknown), Sara Cortés-Lara, (unknown), (unknown), (unknown), Antonio Oliver	1
7	Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane 2022 ·Science Advances ·Ana L. Santos, Dongdong Liu, (unknown), (unknown), (unknown), John T. Li, (unknown), (unknown), (unknown), Jacob L. Beckham, Ciceron Ayala‐Orozco, Anatoly B. Kolomeisky, Lawrence B. Alemany, Antonio Oliver, George P. Tegos, James M. Tour	57
8	Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports 2022 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·Nieves Larrosa, Andrés Canut-Blasco, Natividad Benito, Rafael Cantón, Emilia Cercenado, Fernando Docobo-Pérez, Javier Fernández, Jesús Guinea, (unknown), (unknown), (unknown), Ferrán Navarro, Luis Martínez‐Martínez, Antonio Oliver	1
9	Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada 2022 ·Enfermedades Infecciosas y Microbiología Clínica ·Nieves Larrosa, Andrés Canut-Blasco, Natividad Benito, Rafael Cantón, Emilia Cercenado, Fernando Docobo-Pérez, Javier Fernández, Jesús Guinea, (unknown), Miguel Á. Moreno, (unknown), Ferrán Navarro, Luis Martínez‐Martínez, Antonio Oliver	3
10	Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient 2022 ·Nature Communications ·Rachel M. Wheatley, Julio Diaz Caballero, (unknown), (unknown), (unknown), Natalia Kapel, Claudia Recanatini, Leen Timbermont, Jan Kluytmans, Mark T. Esser, Alícia Lacoma, Cristina Prat, Antonio Oliver, Samir Kumar‐Singh, Surbhi Malhotra‐Kumar, R. Craig MacLean	42
11	Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity 2021 ·Open Forum Infectious Diseases ·Rosa M. Gomila, Gabriel Martorell, Pablo A. Fraile-Ribot, Antonio Doménech‐Sánchez, (unknown), Antonio Oliver, Mercedes García‐Gasalla, Sebastián Albertí	4
12	Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission 2021 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Mercedes García‐Gasalla, (unknown), Pablo A. Fraile-Ribot, (unknown), Adrián Rodríguez, Natalia Martínez‐Pomar, (unknown), Amanda Iglesias, Inés Losada López, Francisco Fanjul, (unknown), (unknown), (unknown), Jaime Pons, Antonio Oliver, Melchor Riera, Javier Murillas	9
13	A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates 2020 ·mBio ·Nathan B. Pincus, Egon A. Ozer, Jonathan P. Allen, Marcus Nguyen, James J. Davis, Deborah R. Winter, (unknown), Cheng‐Hsun Chiu, Laura Zamorano, Antonio Oliver, Alan R. Hauser	18
14	Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics 2020 ·EMBO Molecular Medicine ·Ariane Khaledi, Aaron Weimann, Monika Schniederjans, Ehsaneddin Asgari, (unknown), Antonio Oliver, Gabriel Cabot, Axel Kola, Petra Gastmeier, Michael Hogardt, Daniel E Jonas, (unknown), Andreas Bremges, Alice C. McHardy, Susanne Häußler	127
15	Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model 2020 ·Antimicrobial Agents and Chemotherapy ·(unknown), Phillip J. Bergen, (unknown), Steven C. Wallis, Anton Y. Peleg, Jason A. Roberts, Antonio Oliver, Roger L. Nation, Cornelia B. Landersdorfer	11
16	Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling 2019 ·mSystems ·Gabriel Torrens, Sara B. Hernández, Juan A. Ayala, Bartolomé Moyá, Carlos Juan, Felipe Cava, Antonio Oliver	59
17	Identifying and exploiting genes that potentiate the evolution of antibiotic resistance 2018 ·Nature Ecology & Evolution ·Danna R. Gifford, Victoria Furió, Andrei Papkou, Tom Vogwill, Antonio Oliver, R. Craig MacLean	39
18	Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates 2017 ·Antimicrobial Agents and Chemotherapy ·Bartolomé Moyá, Isabel M. Barceló, Sachin Bhagwat, Mahesh Patel, Germán Bou, Krisztina M. Papp‐Wallace, Robert A. Bonomo, Antonio Oliver	66
19	Inactivation of the Mismatch Repair System in Pseudomonas aeruginosa Attenuates Virulence but Favors Persistence of Oropharyngeal Colonization in Cystic Fibrosis Mice 2007 ·Journal of Bacteriology ·A. Mena, María D. Macià, Núria Borrell, Bartolomé Moyá, (unknown), José L. Pérez, Antonio Oliver	42
20	Characterization of the GO system ofPseudomonas aeruginosa 2002 ·FEMS Microbiology Letters ·Antonio Oliver, (unknown), (unknown)	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact